Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol

Title
Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol
Authors
Keywords
Metformin, Breast cancer prevention, Breast density, Biomarkers, Metabolic syndrome, Metabolomics
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-19
DOI
10.1186/s12885-016-2551-3

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search